Target intelligence / Profile preview

Helicobacter pylori cellular membrane and biofilm matrix

Molecular classification
Bacterial cell envelope, Extracellular matrix, Biofilm
01

Overview

Helicobacter pylori is a Gram-negative bacterium that colonizes the human gastric mucosa, leading to chronic inflammation and various gastrointestinal pathologies. The cellular membrane and the biofilm matrix represent the primary physical barriers protecting the organism from the harsh acidic environment of the stomach and host immune defenses (Kusters et al., 2006, Clin Microbiol Rev). The membrane is characterized by a unique lipopolysaccharide structure and various outer membrane proteins that facilitate adhesion and nutrient transport. The biofilm matrix is a complex assembly of extracellular polymeric substances, including polysaccharides, proteins, and extracellular DNA, which significantly enhances the bacterium's resistance to antibiotic penetration (Hathroubi et al., 2018, Front Microbiol). Therapeutic strategies often target these structures; for instance, beta-lactam antibiotics like amoxicillin interfere with cell wall assembly, while bismuth compounds and certain mucolytics like N-acetylcysteine are used to disrupt the protective biofilm (StatPearls, 2023; Yonezawa et al., 2015, Helicobacter). Understanding the interplay between the membrane and the biofilm is crucial for developing effective treatments against H. pylori-related diseases, including peptic ulcers and gastric cancer.

Other names
H. pylori cell envelopeH. pylori extracellular polymeric substancesH. pylori EPSH. pylori biofilm
02

Mechanism of action

Inhibition of cell wall peptidoglycan synthesis, disruption of bacterial membrane potential, and enzymatic or chemical degradation of the extracellular polymeric substance (EPS) matrix (StatPearls, 2023; Hathroubi et al., 2018, Front Microbiol).

03

Biological functions

Structural integrityPermeability barrierAdhesionImmune evasionAntibiotic resistance
04

Disease associations

InfectionGastritisPeptic ulcer diseaseGastric adenocarcinomaMALT lymphoma
05

Safety considerations

Antibiotic resistanceDisruption of gastric and intestinal microbiotaSystemic absorption of bismuthTreatment failure due to biofilm persistence
06

Interacting drugs

Amoxicillin

7 more in the full profile.

07

Biomarkers

Urea breath testH. pylori stool antigenRapid urease testGastric biopsy histology

Beyond the preview

Go deeper on Helicobacter pylori cellular membrane and biofilm matrix.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Helicobacter pylori cellular membrane and biofilm matrix.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call